Tagged with M

AstraZeneca Gwenael Meneux of AstraZeneca Hong Kong and Macau gives his initial impression of the HK market, outlines his unusual career trajectory and the new innovations AZ is looking to bring to patients in the region.   Gwenael, you have a very interesting and diverse background that is a bit atypical…

Algeria Mourad Ishak, country president Novartis and general manager Sandoz Algeria reveals Novartis’ investment plan for local production, their “under one roof” project for the Novartis entities, and the key strategies to ensure sustainability within the Algerian market.   You’ve been in Algeria for four years. Can you enlighten our viewers…

Algeria Noureddine Issad, general manager of Dar Al Dawa Algeria & Medi Pharma International unveils his ambitions to establish Dar Al Dawa as a major player in the Algerian market through local production of previously untapped product areas and discusses the new position of generics in the Algerian health industry.  …

Spain Ana Fernández of Théa Spain discusses the strategic importance of the Spanish affiliate – the group’s oldest, current trends in Spanish ophthalmology, and what differentiates Théa – as a family-run mid-sized company – from its competitors.   Having taken on your first country manager position in January 2018, what are…

France Prof. Stanislas Lyonnet, director of the Imagine Institute in Paris, France, explains his organization’s unique ecosystem that brings together researchers, physicians, patients and private actors to find the cure to genetic diseases.   Could you please introduce yourself and tell us why you decided to take the helm of the…

Spain Spanish stakeholders have been trailblazing the concept of the “liquid hospital”, which envisions the virtual and physical expansion of healthcare provision beyond the parameters of the traditional centralized hospital structure. The aim is to leverage connectivity, telemedicine, the Internet of Things (IoT) along with social media to co-opt patients, families…

Medtech Aditya Bhattacharji manages Eurasia Group‘s healthcare analysis. He calls for healthcare to be given a new prescription. But, will the private sector write it?   The UK’s National Health Service has crippling sustainability challenges.   With many firms in the midst of or preparing for annual strategic planning sessions, it feels appropriate…

Hong Kong George Kwan, managing director of Hoya Lens, one of the first contact lens manufacturers in Hong Kong, introduces recent new innovation introduced to the market, public sector collaboration, and future strategy.   George, could you start by introducing Hoya Lens Hong Kong to our international audience? Hoya Lens Hong Kong…

Algeria Nawel Baba Hamed, general director of Pierre Fabre Algeria, outlines the French company’s product portfolio in Algeria, its dermatological expertise, and the growing significance of its oncology segment.   Could you introduce our readers to Pierre Fabre and its footprint in Algeria? Pierre Fabre is the second-largest dermo-cosmetic laboratory in…

BIOTECH This week the NHS becomes the first in the world to routinely offer access to breakthrough genomic medicine. Today (1st October 2018) marks a huge stride in ‘precision medicine’ in the UK as the NHS begins to offer gene therapies tailored to individual patients. Hospitals across England have connected to specialist…

Malaysia Jamaludin Elis, country CEO of Chulia Life Sciences Sdn Bhd, discusses the diverse activities of Chulia Group’s various subsidiaries, as well as the group’s upcoming projects in the healthcare industry. He also offers insight into Malaysia’s first medical device innovation park.   Can you present the different healthcare businesses under…

M&A It has been a robust first half in 2018 within the life sciences sector for mergers and acquisition (M&A) and investment activities. Deal-tracking sources demonstrate M&A values witnessed meaningful increases in Q2 2018, with deal volumes in the quarter reminiscent of 2016 and 2017 levels [1]. I and others [234] continue…